€2.98
0.67% yesterday
Xetra, Jul 01, 05:36 pm CET
ISIN
DE0006595101
Symbol
MED
Index

MediClin Stock price

€2.98
+0.02 0.68% 1M
+0.56 23.14% 6M
+0.56 23.14% YTD
+0.46 18.25% 1Y
-0.48 13.87% 3Y
-0.98 24.75% 5Y
-0.48 13.77% 10Y
+1.08 56.83% 20Y
Xetra, Closing price Tue, Jul 01 2025
-0.02 0.67%
ISIN
DE0006595101
Symbol
MED
Index
Sector

Key metrics

Basic
Market capitalization
€142.5m
Enterprise Value
€424.1m
Net debt
€281.6m
Cash
€175.5m
Shares outstanding
47.5m
Valuation (TTM | estimate)
P/E
5.42 | 6.00
P/S
0.19 | 0.18
EV/Sales
0.55 | 0.54
EV/FCF
12.40
P/B
0.63
Dividends
DPS
€0.04
Yield 1Y | 5Y
1.33% | 0.23%
Growth 1Y | 5Y
100.00% | -
Payout 1Y | 3Y
7.69% | 8.16%
Increased
1 Year
Financials (TTM | estimate)
Revenue
€765.7m | €780.8m
EBITDA
€105.7m | €108.1m
EBIT
€54.6m
Net Income
€26.1m | €23.8m
Free Cash Flow
€34.2m
Growth (TTM | estimate)
Revenue
-1.47% | 2.06%
EBITDA
1.98% | -2.04%
EBIT
195.75%
Net Income
541.29% | -4.39%
Free Cash Flow
-10.52%
Margin (TTM | estimate)
Gross
83.54%
EBITDA
13.80% | 13.85%
EBIT
7.13%
Net
3.41% | 3.04%
Free Cash Flow
4.47%
Financial Health
Equity Ratio
24.56%
Return on Equity
11.16%
ROCE
7.45%
ROIC
7.35%
Debt/Equity
2.05
More
EPS
€0.55
FCF per Share
€0.72
Short interest
-
Employees
10.47k
Rev per Employee
€70.00k
Show more

Is MediClin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,951 stocks worldwide.

MediClin Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a MediClin forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a MediClin forecast:

Buy
83%
Hold
17%

Financial data from MediClin

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
766 766
1% 1%
100%
- Direct Costs 126 126
8% 8%
16%
640 640
0% 0%
84%
- Selling and Administrative Expenses 470 470
1% 1%
61%
- Research and Development Expense - -
-
-
106 106
2% 2%
14%
- Depreciation and Amortization 51 51
40% 40%
7%
EBIT (Operating Income) EBIT 55 55
196% 196%
7%
Net Profit 26 26
541% 541%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about MediClin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MediClin Stock News

AD HOC NEWS
28 days ago
MEDICLIN AG / DE0006595101
AD HOC NEWS
28 days ago
MEDICLIN AG / DE0006595101
AD HOC NEWS
2 months ago
MEDICLIN AG / DE0006595101
More MediClin News

Company Profile

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes and medical centers. It operates through the following segments: Post-Acute, Acute and Other Activities. The Post-Acute segment offers subsequent nursing and curative treatment services. The Acute segment focuses on neurology and neurological early rehabilitation, psychosomatic medicine, psychiatry, orthopedic and internal medicine. The Other Activities segment refers to nursing care and service business area including software support, controlling activities, quality assurance and other central services. The company was founded on September 12, 1996 and is headquartered in Offenburg, Germany.

Head office Germany
CEO Joachim Ramming
Employees 10,472
Founded 1996
Website www.mediclin.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today